Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
Vaxcyte Inc.
PCVX | US
59.49
USD-1.28
-2.11%
PCVX | US
Loading StockChartView...
About Vaxcyte Inc.
Sector
Healthcare
Industry
Biotechnology
Earnings date
30/06/2024
As of date
24/04/2026
Close
59.49
Open
60.64
High
61.34
Low
58.65
Vaxcyte Inc. a clinical-stage biotechnology vaccine company develops novel protein vaccines to prevent or treat bacterial infectious diseases. Its lead vaccine candidate is VAX-24 a 24-valent investigational pneumococcal conjugate vaccine for the prevention of invasive pneumococcal disease. The company also develops VAX-31 to protect against these emerging strains and to help address antibiotic resistance; VAX-A1 a novel conjugate vaccine candidate to prevent disease caused by Group A Streptococcus; VAX-PG a novel protein vaccine candidate targeting keystone pathogen responsible for periodontitis; and VAX-GI to prevent Shigella a bacterial illness. The company was formerly known as SutroVax Inc. and changed its name to Vaxcyte Inc. in May 2020. Vaxcyte Inc. was incorporated in 2013 and is headquartered in San Carlos California.
View LessPCVX | US
Risk
37.0
Sharpe
1.45
Luna's Score
58/100
Recommendation
Hold
Luna says (PCVX | US)
What's Working
Low Debt to Equity (< 0.25)
Low Debt to Asset (< 0.2)
Strong Sharpe Ratio (> 1.2)
What's not Working
Price Below SMA10D
Midcap (2B - 10B USD)
High Market Beta (> 0.8)
Volatility Signals
Bearish: Increased Volatility (6-month > 1-month volatility)
Risk Meter
Loading RiskMeterView...
10 days
30.8%1 month
37.0%3 months
40.4%6 months
45.2%Returns
Loading ReturnMeterView...
Fundamental Ratios
PE
-
Fwd. PE
-
Price to book
7.21
Debt to equity
0.01
Debt to assets
0.01
Ent. to EBITDA
-14.43
Ent. to rev.
-
PEG
-
Other Fundamentals
EBITDA
-573.11M
MarketCap
7.36B
MarketCap(USD)
7.36B
Div. yield
-
Op. margin
-
Erngs. growth
-
Rev. growth
-
Ret. on equity
-29.08
Short ratio
5.92
Short perc.
8.86
Market Sentiment (SMA and Price signals)
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bullish (SMA1M > SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
SMAs: Stock Price Trends
Loading MovingAverageView...
Range10D
4.66
Range1M
10.57
Range3M
14.50
Volumes: Market Activity
Volume Averages
Loading VolumeAverageView...
Rel. volume
0.72
Price X volume
49.86M
Peers
Diversifiers
Industry Comparison
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | -14.43 | 0.53 | Cheaper |
| Ent. to Revenue | - | 3,967.00 | - |
| PE Ratio | - | 41.03 | - |
| Price to Book | 7.21 | 15.55 | Cheaper |
| Dividend Yield | - | 2.20 | - |
| Std. Deviation (3M) | 40.42 | 72.80 | Lower Risk |
| Debt to Equity | 0.01 | -1.23 | Expensive |
| Debt to Assets | 0.01 | 0.25 | Cheaper |
| Market Cap | 7.36B | 3.66B | Market Leader |
